Introduction {#s1}
============

Respiratory tract infections (RTIs) are considered the 'bread and butter' of primary care by clinicians across the globe ([@CIT0001]). Of all paediatric visits for RTI, acute cough is the most common complaint, accounting for up to 75% of visits ([@CIT0004],[@CIT0005]). Despite this, most RTIs are self-limiting. A 2008 review by the UK's National Institute of Health and Care Excellence (NICE) concluded that antibiotics do not confer a clinically significant reduction in the time taken to recover from an RTI. NICE guidelines recommend that antibiotics are not prescribed for the majority of paediatric RTIs ([@CIT0003]), and in doing so are consistent with the 2011 European Respiratory Society adult prescribing guidelines ([@CIT0006]). However, antibiotic prescribing rates remain high ([@CIT0007]).

The decision to prescribe antibiotics in primary care is complex and mediated by clinical and non-clinical factors ([@CIT0008],[@CIT0009]). For clinicians, well-described diagnostic uncertainty exists between the presentation of acute cough, and the appropriate management. A recent systematic review ([@CIT0010]) reported an absence of evidence as to whether information available to primary care clinicians at the point of care, namely the findings from the clinical history and examination, can be used to diagnose bacterial or viral infection.

This study aimed to define the sensitivity and specificity of clinical symptoms and signs in identifying bacterial or viral detection from the throat of children presenting to primary care with acute cough. A follow-up study investigated the use of throat swabs as a diagnostic tool by comparing viral and bacterial detection between children when they were unwell with RTI, and when they had recovered.

Materials and methods {#s2}
=====================

Study design and population {#s3}
---------------------------

Primarily a cross-sectional study, with a small follow-up study providing repeated measures for a nested sub-sample of children. Data for the cross-sectional study were collected at baseline primary care consultations as part of the 'TARGET' cohort study, which recruited children aged three months to 16 years presenting to primary care with acute cough and RTI between July 2011 and June 2013 ([@CIT0011]). Primary care practices were recruited via study centres in London, Oxford, Bristol and Southampton, UK. Microbiological samples were collected only at the Bristol centre, primarily from children in the South West of England, and the data from these Bristol centre children only are included in these analyses.

Clinical data collection {#s4}
------------------------

Clinicians completed baseline case report forms for all participants at recruitment recording sociodemographic information, presence and severity of RTI-related symptoms and signs, working diagnosis and antibiotic prescribing decision (Supplementary Data Table S1). Clinicians sought to take throat swabs from all Bristol centre children, and all families were asked to complete online or paper 'symptom diaries' recording presence of six key symptoms for 28 days following recruitment. The 2007 Indices of Multiple Deprivation (IMD) score, linked to the child's home address, was used as a proxy for home deprivation.

Bristol children were invited by post to the follow-up study, and visited again at home by a researcher once the symptom diary record indicated recovery. Repeated clinical data and throat swabs were collected. Only children who were not prescribed antibiotics at the baseline visit were recruited to the follow-up study.

Microbiological sampling {#s5}
------------------------

Throat samples were obtained by sweeping a dual polyurethane foam tipped swab (Medical Wire and Equipment, Corsham, UK) across the mucus membranes of the posterior oropharynx in the region of the pharyngopalatine arch; both tips of the swab touched both sides of the throat. The two swab tips were snapped off and sealed into separate plastic specimen vials containing transport medium. Vials were transported either using a first class Post Office Safebox™ or via existing same-day hospital transport (for practices in the Bristol city area) to the Bristol Centre for Antimicrobial Research and Evaluation (BCARE) at Southmead Hospital, Bristol, UK. The bacterial culture laboratory processed one vial, and sent the second to the viral identification laboratory by hospital courier for identification of viruses and additional bacteria by semi-quantitative real time polymerase chain reaction (qPCR).

Microbe identification {#s6}
----------------------

A total of 12 RTI-related bacteria and 14 RTI-related viruses were sought from all throat swabs. Standard laboratory methods (either bacterial culture or qPCR) were used to identify each microbe. Microbes sought, and detection methods used, are described in detail elsewhere ([@CIT0011]) and summarized in [Table 1](#T1){ref-type="table"}.

###### 

Throat swabs taken by clinician at baseline study visit: methods of microbe identification and prevalence at baseline study visit

  ----------------------------------------------------------------------------------------
  Microbe                                    Method of identification   Prevalence\
                                                                        *n/N* (%)
  ------------------------------------------ -------------------------- ------------------
  Bacteria                                                              

   *Staphylocococcus aureus*                 Culture                    725/2170 (33.4%)

   *Haemophilus influenzae*                  Culture                    513/2170 (23.6%)

   *Streptococcus pneumoniae*                Culture                    322/2170 (14.8%)

   Group A beta haemolytic *Streptococcus*   Culture                    183/2170 (8.4%)

   *Mycoplasma pneumoniae*                   qPCR                       72/2132 (3.4%)

   Group G beta haemolytic *Streptococcus*   Culture                    37/2170 (1.7%)

   *Bordetella pertussis*                    qPCR                       27/2132 (1.3%)

   Group C beta haemolytic *Streptococcus*   Culture                    20/2170 (0.9%)

   *Chlamydophilia pneumoniae*               qPCR                       8/2132 (0.4%)

   *Bordetella parapertussis*                qPCR                       6/2131 (0.3%)

   *Moraxella catarrhalis*                   Culture                    5/2170 (0.2%)

   Group F beta haemolytic *Streptococcus*   Culture                    0/2170 (0.0%)

  Viruses                                                               

   Rhinovirus                                qPCR                       272/2152 (12.6%)

   Enterovirus                               qPCR                       139/2132 (6.5%)

   Respiratory syncytial viruses             qPCR                       129/2181 (5.9%)

   Influenza A                               qPCR                       96/2181 (4.4%)

   Coronavirus                               qPCR                       85/2132 (4.0%)

   Parainfluenzavirus type 3                 qPCR                       61/2181 (2.8%)

   Metapneumoviruses                         qPCR                       57/2181 (2.6%)

   Bocavirus                                 qPCR                       48/2132 (2.3%)

   Influenza B                               qPCR                       48/2181 (2.2%)

   Adenovirus                                qPCR                       41/2179 (1.9%)

   Parainfluenzavirus type 1                 qPCR                       35/2181 (1.6%)

   Parainfluenzavirus type 4                 qPCR                       24/2132 (1.1%)

   Parechovirus                              qPCR                       9/2132 (0.4%)

   Parainfluenzavirus type 2                 qPCR                       5/2181 (0.2%)
  ----------------------------------------------------------------------------------------

qPCR = pathogen identified by quantitative PCR.

Statistical analyses {#s7}
--------------------

In the cross-sectional study, we sought associations between microbes detected from throat swabs at the baseline consultation, and presence and severity of symptoms and signs at the baseline consultation.

Designated outcome variables were the detection of individual or groups of microbes: (i) ≥1 type of RTI-related bacterium, (ii) ≥1 type of RTI-related virus and (iii) single named microbes (where baseline prevalence was ≥5%). Explanatory variables considered were clinical symptom and sign data, socio-demographic data, seasonality and sample transport time.

We used univariable and multivariable logistic regression models to examine predictive values of symptoms and signs for microbe detection, adjusted for demographic variables. Those associated (*P* \< 0.01) with detection of RTI-related microbes in univariable analysis were entered into multivariable models. Manual backward stepwise binary logistic regression was used to obtain adjusted ORs for microbe detection in the presence of symptoms and signs.

Discrimination of each regression model was measured using the area under the Receiver Operating Characteristic (AUROC) curve and its 95% CI. Interactions between explanatory variables in multivariable models were also explored, and further investigated where p-values for the relevant interaction odds ratios were \<0.05.

In the follow-up study, we compared detection rates of (i) ≥1RTI-related bacteria and (ii) ≥1RTI-related virus between samples taken at baseline (symptomatic) and follow-up (asymptomatic) consultations. We also compared detection rates of individual microbes at each visit (microbes with baseline consultation prevalence ≥5% only). A Bonferroni correction was applied due to multiple comparisons, with resultant test-wise significance level of 0.005. Analysis was conducted in STATA v14 (StataCorp. 2015).

Results {#s8}
=======

Ascertainment {#s9}
-------------

Recruitment to the cross-sectional and follow-up studies is detailed in [Figure 1](#F1){ref-type="fig"}.

![Recruitment flowchart and swab availability: cross-sectional and follow-up studies](cmw13601){#F1}

Cross-sectional study {#s10}
---------------------

### Population characteristics {#s11}

The median age of the 2296 children recruited to the cross-sectional study was 3 years \[interquartile range (IQR) 1--6\], with 760 (33%) aged \<12 months. There were 1188 (52%) males, with 2018 (88%) reporting ethnicity as white British (similar to UK Census 2011 data) ([@CIT0012]). Median maternal age at child's birth was 30 years (IQR 26--34), and 466 (21%) mothers were smokers (similar to national data) ([@CIT0013]).

The most common symptoms reported were disturbed sleep, present in 78% of cases, and blocked or runny nose, present in 77%. Antibiotics were immediately prescribed to 745 (32%) children, and delayed prescriptions issued to a further 189 (8%).

### Microbe prevalence in cross-sectional study population {#s12}

In total, ≥1 type of study bacterium was detected in 1257/2113 (59.5%) of samples; ≥1 type of study virus was detected in 894/2127 (42.0%) of samples. There were 672 (32%) swabs positive for at least one type of study bacteria in the absence of any virus; 305 (14%) were positive for at least one type of study virus in the absence of any bacteria; 583 (28%) were positive for both a study bacteria and a study virus; and 549 (26%) swabs had no study microbes detected.

### Individual microbe prevalence in the cross-sectional study sample {#s13}

The prevalence of individual microbes detected from study throat swabs is presented in [Table 1](#T1){ref-type="table"}. The most prevalent bacterium was *Staphylococcus aureus* (detected in 33% of samples), followed by *H. influenzae* (24%), *Streptococcus pneumoniae* (15%) and β haemolytic *Streptococcus* A (8%). The most prevalent viruses were rhinoviruses (detected in 13% of samples), followed by enteroviruses (7%), respiratory syncytial virus (RSV; 6%) and influenza A (4.4%). Enteroviruses and rhinoviruses are genetically similar and some strains may be detected by both rhinovirus and enterovirus PCR tests. However of 407 patients in whom positive results were found with enterovirus and/or rhinovirus assays, only 17 (4.2%) tested positive using both assays. It is not possible to determine if these results represent assay cross-reactivity or dual infection. However for the purposes of this study we considered these 17 samples to represent dual rhinovirus/enterovirus infections.

### Predictors of microbe detection: detection of any bacteria {#s14}

Of all demographic characteristics and symptoms and signs collected (full list in Supplementary Data Table S1), 14 were associated with the detection of ≥1 type of bacterium in univariable analysis (Supplementary Data Table S2). However, in multivariable analysis, only one variable remained associated with the detection of bacteria: low energy during the illness ([Table 2](#T2){ref-type="table"}). The model showed poor discrimination, with AUROC of 0.54 \[95% CI 0.52--0.56\]. Bacterial detection was not associated with clinician-reported diagnosis of bacterial infection: in 119 children for whom clinicians reported specific suspicion of bacterial cause, 54% had RTI-related bacteria detected from their throat swab, versus 60% with no bacterial cause specified (*P* = 0.19).

###### 

Multivariable associations between symptoms, signs and demographic variables and microbe detection

  Variable                                                           Adjusted odds ratio \[95% confidence interval\], *P* value                                                                                                                                                                                                                         
  ------------------------------------------------------------------ ------------------------------------------------------------ ---------------------------- ------------------------------ ---------------------------- ------------------------------ ------------------------------- ------------------------------ ------------------------------ -----
  Age \<2 years                                                      1.65 \[1.36--1.99\], \<0.001                                 ---                          0.31 \[0.20--0.50\], \<0.001   1.53 \[1.19--1.96\], 0.001   ---                            2.48 \[1.69--1.69\], \<0.001    ---                            ---                            ---
  Blocked/ runny nose during the last 24 hours (severe)              ---                                                          ---                          ---                            ---                          ---                            ---                             ---                            1.86 \[1.32--2.63\], \<0.001   ---
  Blocked/ runny nose in the last 24 hours                           1.57 \[1.28--1.93\], \<0.001                                 ---                          ---                            ---                          1.56 \[1.23--1.98\], \<0.001   2.67 \[1.40--1.40\], 0.003      ---                            ---                            ---
  Chills in the last 24 hours (severe)                               ---                                                          ---                          ---                            ---                          3.16 \[1.55--6.41\], 0.001     ---                             ---                            ---                            ---
  Disturbed sleep during the illness                                 ---                                                          ---                          ---                            1.64 \[1.18--2.30\], 0.004   ---                            ---                             ---                            ---                            ---
  Disturbed sleep in the last 24 hours (severe)                      1.52 \[1.21--1.92\], \<0.001                                 ---                          ---                            ---                          ---                            ---                             ---                            ---                            ---
  Dry cough in the last 24 hours                                     ---                                                          ---                          ---                            ---                          1.4 \[1.13--1.72\], 0.002      ---                             ---                            ---                            ---
  Eating less during the illness                                     ---                                                          ---                          1.68 \[1.20--2.37\], 0.003                                  ---                            ---                             ---                            ---                            ---
  Eating less in the last 24 hours                                   ---                                                          ---                          ---                            1.53 \[1.19--1.98\], 0.001   ---                                                            ---                            ---                            ---
  Fever during the illness                                           ---                                                          ---                          ---                            ---                          ---                            ---                             2.19 \[1.46--3.28\], \<0.001   0.53 \[0.41--0.69\], \<0.001   ---
  High respiratory rate (age-adjusted)                               ---                                                          ---                          ---                            0.51 \[0.33--0.78\], 0.002   ---                            ---                             ---                            ---                            ---
  High temperature                                                   1.89 \[1.44--2.49\], \<0.001                                 ---                          ---                            ---                          ---                            2.08 \[1.31--3.31\], 0.002      ---                            ---                            ---
  Illness worsened recently                                          ---                                                          ---                          ---                            ---                          1.41 \[1.11--1.78\], 0.005     ---                             ---                            ---                            ---
  IMD score                                                          0.99 \[0.98--1.00\], 0.001                                   ---                          ---                            ---                          ---                            ---                             ---                            ---                            ---
  Inflamed pharynx                                                   ---                                                          ---                          1.70 \[1.24--2.35\], 0.001     ---                          ---                            ---                             ---                            ---                            ---
  Low energy during the illness                                      ---                                                          1.34 \[1.17--1.67, \<0.001   ---                            ---                          ---                            ---                             ---                            ---                            ---
  Number of children in the home \>1                                 ---                                                          ---                          ---                            ---                          ---                            ---                             0.51 \[0.36--0.73\], \<0.001   ---                            ---
  Pallor                                                             1.34 \[1.08--1.65\], 0.007                                                                ---                            0.62 \[0.46--0.85\], 0.003   ---                            ---                             ---                            ---                            ---
  Productive cough during the illness                                ---                                                          ---                          ---                            ---                          ---                            1.85 \[1.21--2.84\], 0.005      ---                            ---                            ---
  Productive cough in the last 24 hours (severe)                     ---                                                          ---                          ---                            ---                          1.63 \[1.16--2.29\], 0.005     ---                             ---                            ---                            ---
  Recruited October-- March                                          ---                                                          ---                          ---                            ---                          0.61 \[0.49--0.76\], \<0.001   18.22 \[5.74--5.74\], \<0.001   0.44 \[0.31--0.64\], \<0.001   ---                            ---
  Short of breath during the last 24 hours (severe)                  ---                                                          ---                          ---                            ---                          ---                            ---                             ---                            3.59 \[2.07--6.23\], \<0.001   ---
  Short of breath in the last 24 hours                               ---                                                          ---                          ---                            ---                          ---                            2.11 \[1.44--3.11\], \<0.001    ---                            ---                            ---
  Overall strength of relationship with symptoms and signs (AUROC)   0.64 \[0.61--0.66\]                                          0.54 \[0.52--0.56\]          0.66 \[0.62--0.70\]            0.62 \[0.58--0.65\]          0.62 \[0.59--0.65\]            0.80 \[0.77--0.84\]             0.66 \[0.62--0.71\]            0.62 \[0.58--0.65\]            ---

### Detection of any virus {#s15}

Of all demographic characteristics and symptoms and signs collected, 37 were associated with detection of ≥1 type of virus in univariable analysis (Supplementary Data Table S3). In multivariable analysis, 6 variables remained significantly associated with the detection of any virus ([Table 2](#T2){ref-type="table"}). The model showed poor discrimination, with an area under the ROC curve of 0.64 \[95% CI 0.61--0.66\]. Viral detection was not associated with clinician-reported diagnosis of viral infection: in 628 children for whom clinicians reported specific suspicion of viral cause, 42% had RTI-related viruses detected from their throat swab, versus 42% with no viral cause specified (*P* = 0.86).

### Detection of individual microbes {#s16}

Seven of the 26 microbes sought had baseline prevalence ≥5%, and were therefore included in analysis: *S. aureus*, β-haemolytic *Streptococcus* A, *S. pneumoniae*, *H. influenzae*, RSV, enteroviruses and rhinoviruses. No variables were associated with detection of *S. aureus* in univariable analysis. Multivariable associations are presented in [Table 2](#T2){ref-type="table"}. Sensitivity and specificity of multivariable models are also presented in [Table 2](#T2){ref-type="table"} and were essentially poor other than for RSV.

*Bordetella pertussis* was detected in 1.3% of children. Whilst throat swabs are not recommended by Public Health England or the Center for Disease Control for pertussis diagnosis, this suggests potential for untreated infection in the community which should be considered by clinicians and future research.

### Antibiotic prescribing and bacterial detection {#s17}

Antibiotic prescribing rates did not differ between children with RTI-related bacteria detected (40.1% prescribed antibiotics) and children without RTI-related bacterial detection (40.9% prescribed antibiotics, *P* = 0.72).

Follow-up study {#s18}
---------------

### Population characteristics {#s19}

Gender, age, mother's smoking status, index of multiple deprivation score and number of children in the home were comparable in follow-up study recruits and the rest of the cohort. However, follow-up study recruits were more likely to have been breastfed at three months (75% versus 46%), have older mothers (median age: 36 years versus 33 years) and children in the white ethnic group were less prevalent (78% versus 88%).

### Microbe detection {#s20}

Detection rates of ≥1 type of RTI-related microbe were higher at symptomatic baseline consultations than asymptomatic follow-up visits. Difference was more marked for RTI-related viruses (68% versus 26%, *P* \< 0.001) than RTI-related bacteria (56% versus 40%, *P* = 0.01). Analysis of individual microbe prevalence at baseline and follow-up was limited to 10 microbes that were detected at \>5% at the baseline visit in this population ([Table 3](#T3){ref-type="table"}). Detection of *H. influenzae* and rhinovirus was higher at baseline than follow-up (16% versus 0%, *P* \< 0.001 and 19% versus 1%, *P* \< 0.001, respectively). *S. aureus*, coronavirus and enterovirus showed little difference in detection between baseline and follow-up (≤2%, *P* = 0.71, 1.00 and 1.00, respectively). Differences between baseline and follow-up rates were observed for *S. pneumoniae*, influenza B, RSV, β-haemolytic *streptococcus* A and influenza A, which approached but did not meet the strict criteria for significance of *P* ≤ 0.005.

###### 

Detection of individual RTI-related bacteria and viruses in baseline (RTI) and follow-up (non-RTI) samples

  Microbe                 \% samples with virus detected   Decrease in detection between RTI and non-RTI visits   *P* value   *n* (% data missing)                                                                                
  ----------------------- -------------------------------- ------------------------------------------------------ ----------- ---------------------- ---------------------------------------------------------------------------- ---------
  Viruses                                                                                                                                                                                                                         
   Rhinovirus             15 (19%)                         1 (1%)                                                 14%         93%                    \<0.001[\*](#fn-01){ref-type="table-fn"}[^†^](#fn-02){ref-type="table-fn"}   78 (1%)
   RSV                    6 (8%)                           0 (0%)                                                 6%          100%                   0.031[^†^](#fn-02){ref-type="table-fn"}                                      78 (1%)
   Influenza B            5 (5%)                           0 (0%)                                                 5%          100%                   0.13[^†^](#fn-02){ref-type="table-fn"}                                       78 (1%)
   Influenza A            5 (6%)                           1 (1%)                                                 4%          80%                    0.219[^†^](#fn-02){ref-type="table-fn"}                                      78 (1%)
   Coronaviruses          4 (5%)                           3 (4%)                                                 1%          25%                    1.00[^†^](#fn-02){ref-type="table-fn"}                                       74 (6%)
   Enterovirus            4 (5%)                           4 (5%)                                                 0%          0%                     1.00                                                                         74 (6%)
  Bacteria                                                                                                                                                                                                                        
   *H. influenzae*        13 (16%)                         0 (0%)                                                 16%         100%                   \<0.001[\*](#fn-01){ref-type="table-fn"}                                     79 (0%)
   *S. pneumoniae*        11 (14%)                         2 (3%)                                                 12%         82%                    0.023[^†^](#fn-02){ref-type="table-fn"}                                      79 (0%)
   Β-haemolytic strep A   8 (10%)                          2 (3%)                                                 8%          75%                    0.070[^†^](#fn-02){ref-type="table-fn"}                                      79 (0%)
   *S. aureus*            26 (33%)                         24 (30%)                                               3%          8%                     0.71                                                                         79 (0%)

Median time elapsed between baseline (RTI) and follow-up (non-RTI) swabs: 22 days (interquartile range 14--30 days).

Indicates a *P* value \<0.005.

Cell value expected \<5; McNemar's exact test used.

Discussion {#s21}
==========

Summary of principal findings {#s22}
-----------------------------

Our analysis found no evidence that clinical presentation is associated with the detection of one or more RTI-related bacteria, and little evidence that clinical presentation is associated with the detection of one or more RTI-related viruses, in children presenting to primary care with RTI. Clinical presentation was not sufficiently sensitive or specific to predict detection of individual microbes from the throat, with the exception of RSV, which showed reasonable association with four symptoms and signs (blocked nose, high temperature, productive cough and shortness of breath) and two temporal factors (age \<2 years and recruitment in the months of October-March). Our small follow-up study showed that overall, microbe detection was more common in children when they were unwell with RTI than when they had recovered, especially with regard to rhinovirus, RSV, *H. influenzae* and *S. pneumoniae*. There was little or no change in prevalence of enteroviruses, coronaviruses and *S. aureus*, suggesting that they may be commensal or causing subclinical infection in this population.

Strengths and weaknesses of the study {#s23}
-------------------------------------

To our knowledge, this is the first study to examine associations between clinical presentation and a wide range of RTI-related bacteria and viruses in a primary care paediatric population. Participants were broadly representative of local population in gender, ethnicity, deprivation scores and maternal age. Laboratory methods were standardised to ensure consistent results. Children recruited to the follow-up study were broadly representative of the larger study population. The repeated-measures design of the follow-up study, along with recruitment of children who did not receive antibiotics, removed as far as possible any confounding effects of factors such as children's age, siblings, daycare attendance, household deprivation ([@CIT0014]) and antimicrobial prescribing on microbe detection.

These analyses should be regarded as exploratory; their multiplicity increases the risk of Type I error. We used adjusted p-values to reduce this risk, but if we were too stringent in this, we may have introduced Type II errors. Specific prior hypotheses regarding the associations explored would have helped target the analysis, but the absence of prior evidence in this area meant that this was necessarily an exploratory study. Additionally, the sample size of the follow-up study was not large enough to detect whether what appeared to be important variation in detection was in fact due to chance, and the low response rate may have led to a biased sample.

In the absence of a gold standard single sample site from the upper respiratory tract, we took a pragmatic decision to use throat swabs for microbial detection as we judged them to be the sampling method most acceptable to parents and busy primary care clinicians. We acknowledge that, although we might have achieved significantly lower sampling rates, samples obtained and pooled from the oropharynx, nasopharynx and nares could have mitigated the known problem of different optimal sample sites for different microbes ([@CIT0015]) and might have produced more sensitive and specific results for some microbes.

Additionally, to obtain samples which might be diagnostic of lower respiratory tract infections, sampling from the lower respiratory tract would be desirable. However, unless non-invasive alternatives to bronchoscopy and transthoracic pulmonary aspiration become available, sampling from the upper respiratory tract remains the only option to obtain a microbiological respiratory sample in primary care.

This study attempted to examine only 26 microorganisms out of hundreds that exist in the upper respiratory tract; important candidates may have been missed. We have not explored the clinical impact of co-detection or microbial density or load in this paper, but this is planned in future work.

Results in the context of other studies {#s24}
---------------------------------------

Previous work seeking associations between microbe detection and clinical presentation has mostly been conducted in secondary care (hospital settings). A previous systematic review searched primary and secondary care literature for the association of microbe detection with symptoms and signs in children and found a broad absence of evidence in this area ([@CIT0010]). Regarding the follow-up study, Rhedin *et al*. published a case-control study in 2014 which compared viral detection rates in nasopharyngeal aspirates from 225 children attending emergency departments in Sweden with and without symptoms of RTI ([@CIT0016]). Despite differences in study design, population and country, of note is the agreement of the follow-up study findings of a small/no relative decrease between the prevalence of enterovirus and coronavirus in children with and without RTI. Marked decreases in rhinovirus and RSV prevalence were also replicated. Additionally, decreases in rhinovirus and RSV detection were observed by Regamey *et al*. in a 2008 study of nasal swabs from 128 children during and after RTI ([@CIT0017]). However, this study also reported a pronounced fall in coronavirus detection, in contrast to our follow-up study results, perhaps reflecting differences in coronavirus strains circulating in this population.

Meaning of the study: possible explanations and implications for clinicians and policymakers {#s25}
--------------------------------------------------------------------------------------------

A 2007 Health Technology Assessment report discusses the use of validation in evaluating a diagnostic test in the absence of 'an unproblematic and equivocal reference standard'. ([@CIT0018]) The associations demonstrated here between clinical presentation and upper respiratory tract microbes provide little evidence to suggest that some microbes detected from the upper respiratory tract using throat swabs may be aetiologically related to acute RTI and cough. This evidence in isolation is not sufficient, but should be considered alongside evidence from future studies ([@CIT0018]).

We have considered two possible interpretations regarding the fall in prevalence of microbes between the symptomatic and asymptomatic assessments. The first is that the microbes are causally linked to the symptoms. A second explanation is that the inflammatory process in the upper respiratory tract allows some microbes to proliferate, making their detection more likely when children are symptomatic ([@CIT0019],[@CIT0020]).

These results are in line with commonly-held views that rhinovirus is associated with mild, non-febrile cold symptoms. They also demonstrate that β-haemolytic *Streptococcus* A infection is uncommon in children aged \<2 years.

Conclusion {#s26}
==========

The need for a significant reduction in the amount of antibiotics prescribed for RTI in primary care is recognised globally. Definition of a microbiological diagnosis is one of several approaches which, together with research into identifying patients with poor prognostic outcome, improving patient education and improving consultation skills, can tackle the problem. We have demonstrated that, currently, antibiotic prescribing is not targeted to children in whom RTI-related bacteria are detected from the throat during RTI, leaving the question of the effect of targeted antibiotic prescribing unanswered in this group.

Advances in microbiological technology mean that point of care testing of biological samples for the diagnosis of primary care RTI could soon become a reality. In this study, *H. influenzae*, *S. pneumoniae*, Β-haemolytic *streptococcus* A and RSV decreased in prevalence between baseline and follow-up, making them potential candidates to consider in future work exploring point of care tests in this population.

Supplementary Data {#s27}
==================

Supplementary data are available at *Family Practice* online.
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